scholarly article | Q13442814 |
P50 | author | Jeroen Joost Bax | Q77085900 |
Martin Jan Schalij | Q89053249 | ||
Lieselot van Erven | Q114403342 | ||
P2093 | author name string | Suzanne C Cannegieter | |
C Jan Willem Borleffs | |||
Johannes B van Rees | |||
Mihály K de Bie | |||
Enno T van der Velde | |||
Joep Thijssen | |||
P2860 | cites work | Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction | Q28208692 |
Resumption of driving after life-threatening ventricular tachyarrhythmia | Q33146680 | ||
Syncope, driving recommendations, and clinical reality: survey of patients | Q33148460 | ||
Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Ther | Q33151960 | ||
Addendum to "Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North American | Q33154785 | ||
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Gui | Q33156283 | ||
Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators | Q33156418 | ||
Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks | Q33157498 | ||
Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy | Q33158802 | ||
Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator | Q33174543 | ||
Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of P | Q33174830 | ||
Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions | Q33175534 | ||
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure | Q34321811 | ||
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure | Q34386004 | ||
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo | Q34560910 | ||
Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE Group | Q40703058 | ||
Legal and ethical aspects of driving and working in patients with an implantable cardioverter defibrillator | Q40741733 | ||
Death at the wheel. A consideration of cardiovascular disease as a contributory factor to road accidents. | Q43732246 | ||
Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact | Q43848349 | ||
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators | Q44086151 | ||
Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator | Q44974110 | ||
Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators | Q47635686 | ||
Fits and other causes of loss of consciousness while driving. | Q49016966 | ||
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction | Q49171490 | ||
Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study | Q50084690 | ||
Natural death while driving | Q50121383 | ||
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. | Q50744359 | ||
Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) tria | Q51447936 | ||
Implantable cardioverter defibrillators and fitness to drive. | Q53667437 | ||
Time to first pulse after automatic implantable cardioverter defibrillator implantation | Q68140057 | ||
Assessment of the cardiac patient for fitness to drive | Q68182395 | ||
Implantable cardioverter defibrillators and fitness to drive | Q72669638 | ||
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators | Q73280436 | ||
Assessment of the cardiac patient for fitness to drive: 1996 update | Q73434428 | ||
Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators | Q73884395 | ||
P433 | issue | 21 | |
P921 | main subject | defibrillator | Q1450682 |
P304 | page(s) | 2678-2687 | |
P577 | publication date | 2011-06-05 | |
P1433 | published in | European Heart Journal | Q2286839 |
P1476 | title | Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach | |
P478 | volume | 32 |